fludarabine has been researched along with Metastase in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (75.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aymerich, M; Campo, E; Colomer, D; López-Guerra, M; López-Otín, C; Matas-Céspedes, A; Montraveta, A; Pérez-Galán, P; Roldán, J; Rosich, L; Roué, G; Villamor, N; Xargay-Torrent, S | 1 |
| Barkholt, L; Ericzon, BG; Mattsson, J; Omazic, B; Potácová, Z; Remberger, M; Ringdén, O; Söderdahl, G; Wersäll, P | 1 |
| Citrin, DE; Downey, SG; Dudley, ME; Huang, J; Hughes, MS; Kammula, U; Klapper, J; Laurencot, C; Leitman, SF; Morton, K; Restifo, NP; Robbins, PF; Rosenberg, SA; Royal, R; Sherry, R; Smith, FO; Thomasian, A; White, DE; Wunderlich, J; Yang, JC | 1 |
| Baron, F; Baudoux, E; Beguin, Y; Fillet, G; Frère, P; Sautois, B | 1 |
| Anderlini, P; Booser, DJ; Champlin, RE; Cheng, YC; Couriel, DR; de Lima, MJ; Gajewski, JL; Giralt, SA; Hortobagyi, GN; Hosing, C; Jonasch, E; Khouri, IF; Pagliaro, LC; Rondón, G; Tannir, NM; Ueno, NT | 1 |
| Bardou, VJ; Bay, JO; Bilger, K; Blaise, D; Boiron, JM; Braud, AC; Cahn, JY; Chabannon, C; Choufi, B; Faucher, C; Fleury, J; François, S; Gratecos, N; Gravis, G; Maraninchi, D; Michallet, M; Mohty, M; Sotto, JJ; Viens, P; Viret, F | 1 |
| Abati, A; Berman, DM; Dudley, ME; Filie, AC; Gea-Banacloche, J; Gracia, GJ; Jones, SA; Kammula, U; Mangiameli, DP; Mavroukakis, SA; Pelletier, MM; Restifo, NP; Robinson, MR; Rogers, LJ; Rosenberg, SA; Royal, RE; Sherry, RM; Topalian, SL; White, DE; Wunderlich, JR; Yang, JC | 1 |
| Bertetto, O; Busca, A; de Fabritiis, P; Falda, M; Locatelli, F; Novarino, A; Picardi, A; Zeuli, M | 1 |
4 trial(s) available for fludarabine and Metastase
| Article | Year |
|---|---|
Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens.
Topics: Adolescent; Adoptive Transfer; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cells, Cultured; Chemotherapy, Adjuvant; Child; Cyclophosphamide; Female; Humans; Interleukin-15; Interleukin-2; Interleukin-7; Kaplan-Meier Estimate; Lymphocyte Depletion; Lymphocytes, Tumor-Infiltrating; Male; Melanoma; Middle Aged; Myeloablative Agonists; Neoadjuvant Therapy; Neoplasm Metastasis; Pilot Projects; Radiotherapy Dosage; Radiotherapy, Adjuvant; Time Factors; Treatment Outcome; Vidarabine | 2008 |
Non-myeloablative stem cell transplantation with low-dose total body irradiation and fludarabine for metastatic renal cell carcinoma.
Topics: Carcinoma, Renal Cell; Combined Modality Therapy; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Neoplasm Metastasis; Treatment Outcome; Vidarabine; Whole-Body Irradiation | 2003 |
Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Renal Cell; Female; Graft vs Host Disease; Graft vs Tumor Effect; Humans; Male; Melphalan; Middle Aged; Neoplasm Metastasis; Peripheral Blood Stem Cell Transplantation; Remission Induction; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2003 |
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma.
Topics: Adolescent; Adoptive Transfer; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Disease Progression; Drug Resistance, Neoplasm; Female; Humans; Interleukin-2; Lymphocytes, Tumor-Infiltrating; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Skin Neoplasms; Treatment Outcome; Vidarabine | 2005 |
4 other study(ies) available for fludarabine and Metastase
| Article | Year |
|---|---|
The γ-secretase inhibitor PF-03084014 combined with fludarabine antagonizes migration, invasion and angiogenesis in NOTCH1-mutated CLL cells.
Topics: Aged; Amyloid Precursor Protein Secretases; Enzyme Inhibitors; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Mutation; Neoplasm Invasiveness; Neoplasm Metastasis; Neovascularization, Pathologic; Receptor, Notch1; Tetrahydronaphthalenes; Tumor Cells, Cultured; Valine; Vidarabine | 2015 |
Long-Term Follow-Up of Allogeneic Hematopoietic Stem Cell Transplantation for Solid Cancer.
Topics: Adenocarcinoma; Adult; Aged; Bile Duct Neoplasms; Breast Neoplasms; Colonic Neoplasms; Cyclophosphamide; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Kidney Neoplasms; Male; Middle Aged; Myeloablative Agonists; Neoplasm Metastasis; Pancreatic Neoplasms; Prostatic Neoplasms; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2016 |
Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors.
Topics: Acute Disease; Adult; Antilymphocyte Serum; Bone Marrow Transplantation; Busulfan; Chronic Disease; Disease Progression; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Siblings; Stem Cell Transplantation; Survival Analysis; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2004 |
Nonmyeloablative allogeneic blood stem cell transplantation in patients with metastatic solid tumors.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Renal Cell; Colonic Neoplasms; Feasibility Studies; Female; Graft Survival; Graft vs Host Disease; Graft vs Tumor Effect; Humans; Immunosuppressive Agents; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Rectal Neoplasms; Sarcoma; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2006 |